Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa

IF 4.5 3区 医学 Q2 IMMUNOLOGY
Mieke A. van der Mescht , Zelda de Beer , Helen C. Steel , Ronald Anderson , Andries Masenge , Penny L. Moore , Paul Bastard , Jean-Laurent Casanova , Fareed Abdullah , Veronica Ueckermann , Theresa M. Rossouw
{"title":"Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa","authors":"Mieke A. van der Mescht ,&nbsp;Zelda de Beer ,&nbsp;Helen C. Steel ,&nbsp;Ronald Anderson ,&nbsp;Andries Masenge ,&nbsp;Penny L. Moore ,&nbsp;Paul Bastard ,&nbsp;Jean-Laurent Casanova ,&nbsp;Fareed Abdullah ,&nbsp;Veronica Ueckermann ,&nbsp;Theresa M. Rossouw","doi":"10.1016/j.clim.2024.110323","DOIUrl":null,"url":null,"abstract":"<div><p>The African continent reported the least number of COVID-19 cases and deaths of all the continents, although the exact reasons for this are still unclear. In addition, little is known about the immunological profiles associated with COVID-19 mortality in Africa. The present study compared clinical and immunological parameters, as well as treatment outcomes in patients admitted with COVID-19 in Pretoria, South Africa, to determine if these parameters correlated with mortality in this population. The in-hospital mortality rate for the cohort was 15.79%. The mortality rate in people living with HIV (PLWH) was 10.81% and 17.16% in people without HIV (<em>p</em> = 0.395). No differences in age (<em>p</em> = 0.099), gender (<em>p</em> = 0.127) or comorbidities were found between deceased patients and those who survived. All four of the PLWH who died had a CD4+ T-cell count &lt;200 cells/mm<sup>3</sup>, a significantly higher HIV viral load than those who survived (<em>p</em> = 0.009), and none were receiving antiretroviral therapy. Seven of 174 (4%) patients had evidence of auto-antibodies neutralizing Type 1 interferons (IFNs). Two of the them died, and their presence was significantly associated with mortality (<em>p</em> = 0.042). In the adjusted model, the only clinical parameters associated with mortality were: higher fraction of inspired oxygen (FiO2) (OR: 3.308, <em>p</em> = 0.011) indicating a greater need for oxygen, high creatinine (OR: 4.424, <em>p</em> = 0.001) and lower platelet counts (OR: 0.203, <em>p</em> = 0.009), possibly secondary to immunothrombosis. Overall, expression of the co-receptor CD86 (<em>p</em> = 0.021) on monocytes and percentages of CD8+ effector memory 2 T-cells (OR: 0.45, <em>p</em> = 0.027) was lower in deceased patients. Decreased CD86 expression impairs the development and survival of effector memory T-cells. Deceased patients had higher concentrations of RANTES (<em>p</em> = 0.003), eotaxin (p = 0.003) and interleukin (IL)-8 (<em>p</em> &lt; 0.001), all involved in the activation and recruitment of innate immune cells. They also had lower concentrations of transforming growth factor (TGF)-β1 (<em>p</em> = 0.40), indicating an impaired anti-inflammatory response. The immunological profile associated with COVID-19 mortality in South Africa points to the role of aberrate innate immune responses.</p></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"266 ","pages":"Article 110323"},"PeriodicalIF":4.5000,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1521661624004327/pdfft?md5=1c5a69bb103d67dde6d8276584e7e5af&pid=1-s2.0-S1521661624004327-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1521661624004327","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The African continent reported the least number of COVID-19 cases and deaths of all the continents, although the exact reasons for this are still unclear. In addition, little is known about the immunological profiles associated with COVID-19 mortality in Africa. The present study compared clinical and immunological parameters, as well as treatment outcomes in patients admitted with COVID-19 in Pretoria, South Africa, to determine if these parameters correlated with mortality in this population. The in-hospital mortality rate for the cohort was 15.79%. The mortality rate in people living with HIV (PLWH) was 10.81% and 17.16% in people without HIV (p = 0.395). No differences in age (p = 0.099), gender (p = 0.127) or comorbidities were found between deceased patients and those who survived. All four of the PLWH who died had a CD4+ T-cell count <200 cells/mm3, a significantly higher HIV viral load than those who survived (p = 0.009), and none were receiving antiretroviral therapy. Seven of 174 (4%) patients had evidence of auto-antibodies neutralizing Type 1 interferons (IFNs). Two of the them died, and their presence was significantly associated with mortality (p = 0.042). In the adjusted model, the only clinical parameters associated with mortality were: higher fraction of inspired oxygen (FiO2) (OR: 3.308, p = 0.011) indicating a greater need for oxygen, high creatinine (OR: 4.424, p = 0.001) and lower platelet counts (OR: 0.203, p = 0.009), possibly secondary to immunothrombosis. Overall, expression of the co-receptor CD86 (p = 0.021) on monocytes and percentages of CD8+ effector memory 2 T-cells (OR: 0.45, p = 0.027) was lower in deceased patients. Decreased CD86 expression impairs the development and survival of effector memory T-cells. Deceased patients had higher concentrations of RANTES (p = 0.003), eotaxin (p = 0.003) and interleukin (IL)-8 (p < 0.001), all involved in the activation and recruitment of innate immune cells. They also had lower concentrations of transforming growth factor (TGF)-β1 (p = 0.40), indicating an impaired anti-inflammatory response. The immunological profile associated with COVID-19 mortality in South Africa points to the role of aberrate innate immune responses.

南非比勒陀利亚与 COVID-19 死亡率相关的先天性免疫异常。
在各大洲中,非洲大陆报告的 COVID-19 病例和死亡人数最少,但其确切原因尚不清楚。此外,人们对与非洲 COVID-19 死亡率相关的免疫学特征知之甚少。本研究比较了南非比勒陀利亚 COVID-19 患者的临床和免疫学参数以及治疗结果,以确定这些参数是否与该人群的死亡率相关。该组患者的院内死亡率为 15.79%。艾滋病病毒感染者(PLWH)的死亡率为 10.81%,非艾滋病病毒感染者的死亡率为 17.16%(p = 0.395)。死亡患者与存活患者在年龄(p = 0.099)、性别(p = 0.127)或合并症方面均无差异。死亡的四名 PLWH 患者 CD4+ T 细胞计数均为 3,HIV 病毒载量明显高于存活者(p = 0.009),且均未接受抗逆转录病毒治疗。174 名患者中有 7 人(4%)出现了中和 1 型干扰素(IFNs)的自身抗体。其中两人死亡,他们的存在与死亡率显著相关(p = 0.042)。在调整模型中,唯一与死亡率相关的临床参数是:较高的吸入氧分压(FiO2)(OR:3.308,p = 0.011),表明更需要氧气;高肌酐(OR:4.424,p = 0.001)和较低的血小板计数(OR:0.203,p = 0.009),可能是继发于免疫血栓形成。总体而言,死亡患者的单核细胞共受体 CD86 表达量(p = 0.021)和 CD8+ 效应记忆 2 T 细胞百分比(OR:0.45,p = 0.027)均较低。CD86 表达减少会影响效应记忆 T 细胞的发育和存活。死亡患者的 RANTES(p = 0.003)、Eotaxin(p = 0.003)和白细胞介素(IL)-8(p = 0.003)浓度较高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical immunology
Clinical immunology 医学-免疫学
CiteScore
12.30
自引率
1.20%
发文量
212
审稿时长
34 days
期刊介绍: Clinical Immunology publishes original research delving into the molecular and cellular foundations of immunological diseases. Additionally, the journal includes reviews covering timely subjects in basic immunology, along with case reports and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信